Business Context and Reporting Period
Company: Photronics, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended May 4, 1997.
Business Overview: Photronics operates a global network of nine manufacturing facilities (five in the U.S., two in Europe, one in Singapore, and a minority interest in Korea) producing photomasks for semiconductor manufacturers. The company is currently expanding capacity with new facilities in Manchester, U.K., and Austin, Texas.
Key Financial Metrics
| Metric (in thousands) | Six Months Ended May 4, 1997 | Six Months Ended April 30, 1996 |
|---|---|---|
| Net Sales | $89,063 | $75,182 |
| Gross Profit | $33,433 | $29,119 |
| Gross Margin | 37.5% | 38.7% |
| Operating Income | $17,230 | $15,139 |
| Net Income | $11,509 | $9,918 |
| Diluted EPS | $0.93 | $0.82 |
| Cash & Equivalents (End of Period) | $11,115 | $28,860 |
| Long-Term Debt | $17,023 | $1,987 |
| Capital Expenditures | $32,540 | $18,621 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 18.5% year-over-year for the six-month period, driven by a 40% contribution from new international operations and higher demand for high-end photomasks.
- Margin Compression: Gross margins declined from 38.7% to 37.5%. Management attributes this to the ramp-up of new manufacturing facilities, lower margins in international operations, and increased labor and depreciation costs associated with capacity expansion.
- Profitability: Net income rose 16.0% to $11.5 million. This growth included a one-time gain of approximately $1.1 million from the sale of investment securities.
- Liquidity Shift: Cash and cash equivalents decreased by $15.6 million due to significant capital expenditures ($32.5 million) for facility construction and equipment. To offset this, the company borrowed $15.0 million under its revolving credit facility.
- Debt Structure: Long-term debt increased significantly from $1.99 million to $17.02 million, primarily due to the $15 million draw on the revolving credit facility.
Guidance, Outlook, and Risks
- Capital Commitments: The company has outstanding commitments for approximately $70 million in capital expenditures to fund ongoing capacity expansion and R&D for next-generation photomasks.
- Financing Activity: Subsequent to the reporting period (May 29, 1997), the company sold $103.5 million in 6% convertible subordinated notes due in 2004. Proceeds were used to repay the $15 million revolving credit facility balance.
- Operational Outlook: Management expects foreign revenue trends to continue increasing. Fixed operating costs are anticipated to rise with capacity expansion, which the company expects to offset with increased net sales.
- Risks: Forward-looking statements are subject to risks including market uncertainties, pricing pressures, competition, and manufacturing efficiencies. The company is also subject to the adoption of new accounting standards (SFAS 128) regarding EPS calculation in fiscal 1998.
Investor Verification Checklist
- Debt Repayment: Verify the successful repayment of the $15 million revolving credit facility using proceeds from the May 29, 1997 convertible note offering.
- Capital Expenditure Utilization: Monitor the ramp-up timeline for the new Manchester, U.K., and Austin, Texas, facilities to ensure they reach utilization levels sufficient to restore gross margins.
- International Margins: Track the margin performance of new international operations to confirm they approach domestic levels as volume increases.
- One-Time Gains: Exclude the $1.1 million gain on the sale of investments when analyzing core operating profitability trends.
- Convertible Note Dilution: Assess the potential dilution impact of the 1.85 million shares issuable upon conversion of the new subordinated notes.